Fowl Cholera in Poultry: Pasteurella multocida Infection

Etiology

Fowl cholera is a contagious bacterial disease of domestic and wild birds caused by the Gram-negative coccobacillus Pasteurella multocida [1, 2]. The organism belongs to the family Pasteurellaceae and is characterized by bipolar staining when treated with Wright or Giemsa stains [1, 3]. P. multocida is a facultative anaerobe that grows readily on blood agar or tryptic soy agar under microaerophilic conditions, producing distinct colonies that are smooth, mucoid, and iridescent when viewed by oblique transmitted light [2, 4]. Capsular serogroups (A, B, D, E, F) and somatic lipopolysaccharide serotypes (1 through 16) define the antigenic diversity of the species, with capsular type A and somatic serotypes 1, 3, and 4 being most frequently associated with avian disease [1, 3, 5]. The fowl cholera bacterial capsule is a key virulence determinant that inhibits phagocytosis and complement-mediated opsonization [3, 6]. Additional virulence factors include the outer membrane proteins, siderophore-dependent iron acquisition systems, and the filamentous hemagglutinin involved in adhesion to respiratory epithelium [4, 7].

Epidemiology

Fowl cholera occurs worldwide and affects chickens, turkeys, ducks, geese, and numerous wild avian species [1, 2]. Turkeys are generally more susceptible than chickens, with mortality rates in acute outbreaks reaching 50% or higher in unvaccinated flocks [1, 5]. The disease is more common in adult birds, particularly layers and breeders, although outbreaks in growing birds are reported [2, 4]. The primary reservoirs are chronically infected carrier birds that harbor the organism in the choanal cleft, tonsils, or nasopharynx without exhibiting clinical signs [1, 3]. Mechanical transmission occurs via contaminated feed, water, equipment, and personnel [5]. Rodents, cats, and other mammals can serve as vectors [2]. The bacterium survives for weeks in organic material, moist environments, and water, facilitating indirect transmission within and between flocks [4, 6]. Stressors including overcrowding, poor ventilation, nutritional deficiencies, intercurrent viral infections, and sudden temperature changes precipitate clinical disease in carrier flocks [1, 7].

Pathogenesis

The pathogenesis of fowl cholera begins with inhalation or ingestion of P. multocida followed by colonization of the upper respiratory tract mucosa [3, 6]. The bacteria adhere to ciliated epithelial cells via hemagglutinins and lipopolysaccharide structures, then invade the submucosa and enter the lymphatic circulation [4, 7]. The capsule and outer membrane proteins confer resistance to phagocytosis and complement-mediated killing, allowing the bacteria to proliferate in the bloodstream and produce a fulminant septicemia [1, 3]. Endotoxin (lipopolysaccharide) released during bacterial lysis triggers a systemic inflammatory response characterized by widespread vascular damage, disseminated intravascular coagulation, and multiorgan failure [2, 5]. In chronic infections, localized colonization occurs in the wattles, sinuses, joints, and oviduct, often with minimal systemic involvement [1, 4]. The molecular basis of host specificity and tissue tropism remains an active area of investigation, with phase variation in capsular expression and lipopolysaccharide structure contributing to immune evasion [3, 7].

Clinical Signs

The clinical presentation of fowl cholera varies with disease form, host species, and strain virulence [1, 2].

Peracute Form

In peracute disease, birds are found dead without premonitory signs [1, 5]. Mortality spikes abruptly, often within 12 to 24 hours of the first observed death [2, 4].

Acute Form

Acute fowl cholera is characterized by fever, anorexia, depression, ruffled feathers, and mucoid or blood-tinged oral discharge [1, 3]. Respiratory signs include dyspnea, tachypnea, and rales [2, 5]. Cyanosis of the comb and wattles is common, reflecting systemic hypoxia and endotoxemia [1, 4]. Diarrhea is frequently observed; feces may be greenish, yellowish, or hemorrhagic [3, 6]. In laying birds, egg production drops precipitously [2, 5]. Death typically occurs within 48 to 72 hours of clinical onset, with mortality rates of 20% to 50% in chickens and higher in turkeys [1, 4].

Chronic Form

Chronic fowl cholera develops in birds that survive acute infection or in flocks exposed to low-virulence strains [1, 3]. Localized infections manifest as swollen wattles (wattle edema), conjunctivitis, sinusitis, torticollis from otitis media or meningitis, swollen joints (arthritis), and sternal bursitis [2, 5, 6]. Respiratory rales and mild depression may persist [1, 4]. Chronic infections can last for weeks and predispose birds to secondary bacterial infections [3, 7].

The following table summarizes the key clinical signs by form.

Postmortem Pathology

Gross lesions in acute fowl cholera reflect systemic septicemia [1, 4]. Petechial and ecchymotic hemorrhages are present on the epicardium, serosal membranes, and abdominal fat [2, 5]. The liver is enlarged, friable, and studded with multiple pale necrotic foci (1 to 3 mm in diameter) that are pathognomonic in many cases [1, 3, 6]. The spleen is congested and enlarged [2, 4]. Pulmonary congestion, edema, and fibrinous pneumonia are common, particularly in turkeys [1, 5]. The duodenal mucosa is hemorrhagic and catarrhal, and the intestinal lumen may contain blood-tinged fluid [3, 6].

In chronic fowl cholera, localized purulent or fibrinous exudate accumulates in the wattles, infraorbital sinuses, joints, tendon sheaths, and oviduct [1, 4]. The affected wattle is edematous, firm, and may caseate centrally [2, 5]. Arthritis is characterized by turbid synovial fluid, periarticular fibrosis, and cartilage erosion [3, 7]. Airsacculitis and pericarditis are occasionally observed [1, 6].

Histopathologic examination reveals multifocal hepatic necrosis with a central accumulation of heterophils and fibrin, bacterial emboli in hepatic sinusoids and renal glomeruli, and diffuse vascular congestion [1, 3, 4]. Gram-negative bacilli are often visible within macrophages and extracellularly in liver, spleen, and lung sections [2, 5].

Diagnostics

Definitive diagnosis of fowl cholera requires isolation and identification of P. multocida from clinical samples or lesions [1, 4, 6].

Sample Collection

Samples should be collected aseptically from bone marrow, liver, spleen, lung, and heart blood of recently dead (within a few hours) or moribund birds [2, 5]. Swabs from the choanal cleft or trachea are useful for live bird sampling [1, 3]. For chronic lesions, aspirates of wattle edema, joint fluid, or sinus exudate are appropriate [4, 7].

Bacteriological Culture

Samples are streaked onto 5% sheep blood agar or tryptic soy agar and incubated at 37 degrees Celsius in 5% carbon dioxide for 18 to 24 hours [1, 2]. P. multocida produces characteristic non-hemolytic, dewdrop-like colonies that are mucoid and exhibit iridescence under oblique transmitted light [3, 4]. Gram staining reveals small Gram-negative coccobacilli with bipolar staining [1, 5]. Biochemical identification is based on positive reactions for oxidase, catalase, and indole, and acid production from glucose, sucrose, and mannitol, with negative urease and ornithine decarboxylase activity [2, 6].

Molecular Detection

Polymerase chain reaction (PCR) assays targeting the kmg1 or ompH genes provide rapid, sensitive, and specific detection of P. multocida directly from clinical samples [3, 7]. Multiplex PCR can simultaneously identify capsular serogroups and somatic serotypes, enabling epidemiological typing [4, 5]. Real-time quantitative PCR allows quantification of bacterial load in tissues and secretions [6].

Serological and Molecular Typing

Beyond capsular typing, methods including restriction endonuclease analysis (REA), pulsed-field gel electrophoresis (PFGE), and whole-genome sequencing (WGS) provide high-resolution strain discrimination for outbreak tracing and epidemiological surveillance [1, 3, 7]. Serological assays such as agglutination tests and enzyme-linked immunosorbent assays (ELISAs) are available for flock-level exposure monitoring but have limited diagnostic utility for individual birds due to serotype diversity and variable antibody responses [2, 5].

The following Mermaid diagram outlines a diagnostic workflow for fowl cholera.

flowchart TD
    A[Clinical signs: sudden death, cyanosis, oral discharge, diarrhea], > B[Postmortem examination]
    A, > C[Live bird sampling: choanal/tracheal swab]
    B, > D[Lesions: hepatic necrosis, petechiae, splenomegaly]
    D, > E[Aseptic collection: liver, spleen, heart blood, bone marrow]
    C, > F[Aspirate: wattle edema, joint fluid (chronic cases)]
    E, > G[Gram stain: bipolar coccobacilli]
    F, > G
    G, > H[Culture on blood agar, 37°C 5% CO2]
    H, > I[Mucoid iridescent colonies at 18-24 h]
    I, > J[Biochemical identification: oxidase+, catalase+, indole+]
    I, > K[PCR: kmg1/ompH target genes]
    J, > L[Confirm: P. multocida]
    K, > L
    L, > M[Capsular/somatic typing: multiplex PCR, REA, WGS]
    M, > N[Epidemiological analysis & outbreak management]

Differential Diagnosis

Fowl cholera must be differentiated from other septicemic diseases of poultry, including highly pathogenic avian influenza, Newcastle disease, salmonellosis (particularly Salmonella Gallinarum pullorum disease and fowl typhoid), colibacillosis, erysipelas, and infectious coryza [1, 2, 4]. Acute fowl cholera closely resembles avian influenza and Newcastle disease; laboratory confirmation is essential because clinical signs and gross lesions overlap significantly [3, 5]. Swollen wattles in chronic fowl cholera may mimic wattle edema caused by trauma or local infection with Escherichia coli or other pyogenic bacteria [1, 6]. Arthritis from chronic fowl cholera must be distinguished from that caused by Mycoplasma synoviae, Staphylococcus aureus, or Avibacterium (Haemophilus) paragallinarum [2, 7].

Treatment and Antimicrobial Therapy

Antimicrobial therapy is most effective when initiated early in the course of acute disease [1, 4]. Water-soluble antibiotics are commonly administered via drinking water for flock-level treatment, including tetracyclines (oxytetracycline, chlortetracycline), sulfonamides (sulfadimethoxine, sulfamethazine), potentiated sulfonamides (trimethoprim-sulfadiazine), penicillins (amoxicillin, ampicillin), and fluoroquinolones (enrofloxacin, difloxacin) [2, 5, 6]. Selection of antimicrobial agents should be guided by in vitro susceptibility testing due to the global prevalence of acquired resistance to tetracyclines, sulfonamides, and streptomycin [3, 7]. As a general principle, treatment should be administered for 5 to 7 consecutive days to reduce the risk of relapse and selection of resistant subpopulations [1, 4]. Individual birds with chronic localized lesions such as wattle edema or arthritis may benefit from parenteral administration of long-acting oxytetracycline, ceftiofur, or florfenicol [2, 5]. Surgical drainage of wattle abscesses and joint exudates has been described as an adjunctive measure in valuable breeding stock [1, 6]. In all cases, antimicrobial use must comply with local regulatory frameworks governing veterinary prescription, withdrawal periods, and prudent use to minimize selection of antimicrobial-resistant bacteria [3, 7].

Prevention and Control

Control of fowl cholera relies on a comprehensive biosecurity program, effective vaccination, and management practices that minimize stress and pathogen circulation [1, 2, 4].

Biosecurity

Strict biosecurity protocols are essential to prevent introduction and spread of the fowl cholera bacterial agent [1, 5]. Measures include all-in/all-out flock management, cleaning and disinfection of facilities between cycles, rodent and wild bird control, disinfection of footwear and equipment, and sourcing birds from certified P. multocida free suppliers [2, 3]. Water sources should be monitored and sanitized because the bacterium can survive for extended periods in untreated water [4, 6]. Quarantine of incoming birds and separation of flocks by age group reduce transmission risk [1, 7].

Vaccination

Vaccination is widely used in endemic areas and high-risk production systems [1, 5]. Available vaccine formulations include bacterins (killed whole-cell vaccines), live attenuated vaccines (e.g., the CU strain, M-9 strain, and PM-1 strain), and recombinant subunit vaccines targeting outer membrane proteins or lipopolysaccharide antigens [2, 3, 6]. Bacterins provide serotype-specific protection and require multiple doses; they reduce clinical disease but do not consistently prevent colonization or the carrier state [1, 4]. Live attenuated vaccines are administered by drinking water or wing web stab and induce broader cross-protective immunity through stimulation of both humoral and cell-mediated responses [3, 5]. Autogenous vaccines prepared from flock-specific field isolates are sometimes used when commercial vaccines fail to provide adequate protection [2, 7]. Revaccination schedules are determined by local challenge pressure and duration of immunity conferred by the selected product [1, 4].

Management

Management practices that reduce stress and improve host resistance are integral to control programs [1, 5]. These include optimizing stocking density, providing adequate ventilation, ensuring balanced nutrition, managing ammonia levels in litter, and promptly addressing intercurrent infections with immunosuppressive viruses such as infectious bursal disease virus, Marek disease virus, and chicken infectious anemia virus [2, 3, 6]. Eradication of the carrier state is generally not feasible in commercial poultry, but partial depopulation of affected houses, thorough cleaning, and extended downtime (at least 2 to 3 weeks) between flocks can reduce environmental contamination and break the cycle of reinfection [1, 4, 7].

Public Health Considerations

Pasteurella multocida is an opportunistic zoonotic pathogen capable of causing soft tissue infections following bites or scratches from infected animals, including poultry [1, 2]. Human infection is rare and typically occurs in immunocompromised individuals or poultry processing workers with percutaneous exposure [3, 4]. Fowl cholera in poultry does not represent a foodborne hazard because the organism is inactivated by proper cooking; however, occupational hygiene measures including glove use and wound care are recommended for personnel who handle infected birds or contaminated materials [1, 5].

Conclusions

Fowl cholera is a globally significant bacterial disease of poultry that manifests as peracute septicemia, acute respiratory illness, or chronic localized infections. The fowl cholera bacterial pathogen P. multocida employs an array of capsular and surface-associated virulence factors to colonize the respiratory tract, evade host defenses, and produce systemic disease. Rapid diagnosis based on clinical signs, characteristic postmortem lesions, bacteriological culture, and molecular detection is essential for timely intervention. Antimicrobial therapy combined with comprehensive vaccination and biosecurity programs remains the cornerstone of control. The ongoing evolution of antimicrobial resistance and emergence of novel serotypes underlines the need for continuous surveillance and refinement of preventive strategies.

References

[1] Glisson JR, Hofacre CL, Christensen JP. Pasteurellosis. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020.

[2] Shivaprasad HL, Christensen JP, Bisgaard M. Fowl cholera. In: Saif YM, editor. Diseases of Poultry. 13th ed. Wiley-Blackwell; 2013.

[3] Boyce JD, Harper M, Wilkie I, Adler B. Pasteurella multocida. In: Gyles CL, Prescott JF, Songer JG, Thoen CO, editors. Pathogenesis of Bacterial Infections in Animals. 4th ed. Wiley-Blackwell; 2010.

[4] Christensen JP, Bisgaard M. Fowl cholera. In: Pattison M, McMullin P, Bradbury JM, Alexander DJ, editors. Poultry Diseases. 6th ed. Elsevier; 2008.

[5] Merck Veterinary Manual. Fowl Cholera. In: Merck Publishing; 2023.

[6] Harper M, Boyce JD, Adler B. Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiology Letters. 2006;265(1):1-10.

[7] Dabo SM, Confer AW, Quijano-Blas RA. Molecular and immunological characterization of Pasteurella multocida. Animal Health Research Reviews. 2000;1(2):97-112. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.